Shanghai Haohai Biological Technology Co. Ltd Capital Reinvestment Ratio
Shanghai Haohai Biological Technology Co. Ltd capital reinvestment ratio. Shanghai Haohai Biological Technology Co. Ltd (5HB) has a Capital Reinvestment Ratio of 0.37x as of June 2023, meaning it reinvests 0% of its operating cash flow (€141.99 Million) in capital expenditures (€53.01 Million). Check Shanghai Haohai Biological Technology Co cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Shanghai Haohai Biological Technology Co. Ltd (2016–2025)
Capital reinvestment ratio of Shanghai Haohai Biological Technology Co. Ltd from 2016 to 2025. This chart tracks Shanghai Haohai Biological Technology Co. Ltd's Capital Reinvestment Ratio across 10 annual periods. Also explore net asset momentum of Shanghai Haohai Biological Technology Co to track the company's year-over-year net asset growth rate.
Shanghai Haohai Biological Technology Co. Ltd Capital Reinvestment Ratio by Year (2016–2025)
Shanghai Haohai Biological Technology Co. Ltd capital reinvestment ratio by year from 2016 to 2025. For the full cash flow conversion analysis, see 5HB operating cash flow.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.38x | €490.97 Million | €186.94 Million | ▼ -32.1% |
| 2024 | 0.56x | €648.57 Million | €363.49 Million | ▲ +3.6% |
| 2023 | 0.54x | €634.45 Million | €343.10 Million | ▼ -59.5% |
| 2022 | 1.34x | €231.30 Million | €309.21 Million | ▲ +68.9% |
| 2021 | 0.79x | €342.29 Million | €270.88 Million | ▲ +9.3% |
| 2020 | 0.72x | €262.07 Million | €189.70 Million | ▲ +1.4% |
| 2019 | 0.71x | €348.91 Million | €249.18 Million | ▲ +84.8% |
| 2018 | 0.39x | €391.28 Million | €151.21 Million | ▼ -1.3% |
| 2017 | 0.39x | €343.06 Million | €134.29 Million | ▲ +31.7% |
| 2016 | 0.30x | €254.49 Million | €75.67 Million | — |